Predictive Oncology Inc
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D cult… Read more
Predictive Oncology Inc (POAI) - Net Assets
Latest net assets as of September 2025: $-77.43 Million USD
Based on the latest financial reports, Predictive Oncology Inc (POAI) has net assets worth $-77.43 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.14 Million) and total liabilities ($80.57 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-77.43 Million |
| % of Total Assets | -2467.98% |
| Annual Growth Rate | N/A |
| 5-Year Change | -107.67% |
| 10-Year Change | -104.93% |
| Growth Volatility | 6540.58 |
Predictive Oncology Inc - Net Assets Trend (2008–2024)
This chart illustrates how Predictive Oncology Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Predictive Oncology Inc (2008–2024)
The table below shows the annual net assets of Predictive Oncology Inc from 2008 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-202.61K | -102.45% |
| 2023-12-31 | $8.27 Million | -62.00% |
| 2022-12-31 | $21.77 Million | -45.94% |
| 2021-12-31 | $40.27 Million | +1423.67% |
| 2020-12-31 | $2.64 Million | -76.47% |
| 2019-12-31 | $11.23 Million | +20903.72% |
| 2018-12-31 | $53.47K | -98.01% |
| 2017-12-31 | $2.69 Million | +191.43% |
| 2016-12-31 | $923.68K | -77.54% |
| 2015-12-31 | $4.11 Million | +174.56% |
| 2014-12-31 | $-5.52 Million | -71.39% |
| 2013-12-31 | $-3.22 Million | +2.57% |
| 2012-12-31 | $-3.30 Million | -22.19% |
| 2011-12-31 | $-2.70 Million | -23.46% |
| 2010-12-31 | $-2.19 Million | +6.51% |
| 2009-12-31 | $-2.34 Million | -656.85% |
| 2008-12-31 | $-309.44K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Predictive Oncology Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 17728247900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $66.67K | % |
| Other Components | $180.16 Million | % |
| Total Equity | $-202.61K | 100.00% |
Predictive Oncology Inc Competitors by Market Cap
The table below lists competitors of Predictive Oncology Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Central China Real Estate Limited
PINK:CNLLF
|
$10.05 Million |
|
Aktis Oncology, Inc. Common stock
NASDAQ:AKTS
|
$10.05 Million |
|
First Physicians Capital Group Inc
PINK:FPCG
|
$10.05 Million |
|
BLACKROCK (BLQA.SG)
STU:BLQA
|
$10.06 Million |
|
Cords Cable Industries Limited
NSE:CORDSCABLE
|
$10.04 Million |
|
ArborGen Holdings Limited
PINK:RUBNF
|
$10.04 Million |
|
Lukas Biomedical Inc.
TWO:6814
|
$10.04 Million |
|
Century Extrusions Limited
NSE:CENTEXT
|
$10.04 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Predictive Oncology Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 8,271,780 to -202,610, a change of -8,474,390 (-102.4%).
- Net loss of 12,201,261 reduced equity.
- New share issuances of 4,960,562 increased equity.
- Other comprehensive income increased equity by 792.
- Other factors decreased equity by 1,234,483.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-12.20 Million | -6022.04% |
| Share Issuances | $4.96 Million | +2448.33% |
| Other Comprehensive Income | $792.00 | +0.39% |
| Other Changes | $-1.23 Million | -609.29% |
| Total Change | $- | -102.45% |
Book Value vs Market Value Analysis
This analysis compares Predictive Oncology Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | $-446.12 | $5.48 | x |
| 2009-12-31 | $-1301.13 | $5.48 | x |
| 2010-12-31 | $-986.29 | $5.48 | x |
| 2011-12-31 | $-30036.27 | $5.48 | x |
| 2012-12-31 | $-794.99 | $5.48 | x |
| 2013-12-31 | $-366.15 | $5.48 | x |
| 2014-12-31 | $-595.06 | $5.48 | x |
| 2015-12-31 | $263.38 | $5.48 | x |
| 2016-12-31 | $65.44 | $5.48 | x |
| 2017-12-31 | $84.61 | $5.48 | x |
| 2018-12-31 | $0.83 | $5.48 | x |
| 2019-12-31 | $78.26 | $5.48 | x |
| 2020-12-31 | $4.42 | $5.48 | x |
| 2021-12-31 | $14.68 | $5.48 | x |
| 2022-12-31 | $5.91 | $5.48 | x |
| 2023-12-31 | $2.06 | $5.48 | x |
| 2024-12-31 | $-0.04 | $5.48 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Predictive Oncology Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -751.39%
- • Asset Turnover: 0.33x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-1262.48%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.73 Million |
| 2009 | 0.00% | -18378.53% | 0.05x | 0.00x | $-2.66 Million |
| 2010 | 0.00% | -469690.63% | 0.00x | 0.00x | $-1.13 Million |
| 2011 | 0.00% | -4643.02% | 0.22x | 0.00x | $-4.22 Million |
| 2012 | 0.00% | -3931.81% | 0.51x | 0.00x | $-7.09 Million |
| 2013 | 0.00% | -2009.36% | 0.79x | 0.00x | $-9.08 Million |
| 2014 | 0.00% | -718.14% | 1.06x | 0.00x | $-6.28 Million |
| 2015 | -116.48% | -732.10% | 0.12x | 1.37x | $-5.20 Million |
| 2016 | -706.52% | -1429.59% | 0.16x | 3.04x | $-6.62 Million |
| 2017 | -287.77% | -1182.98% | 0.18x | 1.35x | $-8.02 Million |
| 2018 | -18863.10% | -714.51% | 0.38x | 69.36x | $-10.09 Million |
| 2019 | -172.65% | -1373.71% | 0.06x | 1.99x | $-20.51 Million |
| 2020 | -979.47% | -2066.99% | 0.10x | 4.94x | $-26.15 Million |
| 2021 | -48.82% | -1383.65% | 0.03x | 1.09x | $-23.68 Million |
| 2022 | -118.25% | -1709.62% | 0.06x | 1.18x | $-27.91 Million |
| 2023 | -169.06% | -859.13% | 0.11x | 1.74x | $-14.81 Million |
| 2024 | 0.00% | -751.39% | 0.33x | 0.00x | $-12.18 Million |
Industry Comparison
This section compares Predictive Oncology Inc's net assets metrics with peer companies in the Software - Infrastructure industry.
Industry Context
- Industry: Software - Infrastructure
- Average net assets among peers: $237,144,588
- Average return on equity (ROE) among peers: -85.78%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Predictive Oncology Inc (POAI) | $-77.43 Million | 0.00% | N/A | $10.04 Million |
| Automatic Bank Services Limited (ABANF) | $231.37 Million | 16.52% | 0.19x | $269.02 Million |
| ACI Worldwide Inc (ACIW) | $76.50 Million | 16.47% | 0.61x | $4.01 Billion |
| Adyen N.V (ADYYF) | $389.78 Million | 18.29% | 1.92x | $34.24 Billion |
| Aeva Technologies, Inc. Common Stock (AEVA) | $99.35 Million | -153.25% | 0.48x | $418.95 Million |
| Aeva Technologies, Inc. Warrants (AEVAW) | $456.38 Million | -22.32% | 0.05x | $3.74 Million |
| Affluence Corporation (AFFU) | $-639.00K | 0.00% | 0.00x | $3.98K |
| Axe Compute Inc. (AGPU) | $923.68K | -706.52% | 2.04x | $2.86 Million |
| C3 Ai Inc (AI) | $838.30 Million | -34.44% | 0.22x | $1.15 Billion |
| iLearningEngines, Inc. (AILE) | $264.32 Million | 1.83% | 0.09x | $17.39 Million |
| PowerFleet, Inc. (AIOT) | $15.17 Million | 5.61% | 0.31x | $383.57 Million |